[]

X L Zhu1, X J Huang1, Y Wang1

  • 1Peking University People's Hospital, Peking University Institute of Hematology, National Clinical Research Center for Hematologic Disease, Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation, Beijing 100044, China.

概括

造血干细胞移植 (HSCT) 对于治疗急性髓性白血病 (AML) 仍然至关重要. 本综述涵盖了HSCT指示,供体选择以及改善AML患者治疗结果的新策略的进展.